Medical Stocks To Add to Your Watchlist – November 9th

Humana, Hims & Hers Health, Boston Scientific, Stryker, Gilead Sciences, Danaher, and Medtronic are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of companies involved in healthcare, such as pharmaceutical and biotechnology firms, medical-device makers, and healthcare providers. For investors, the term covers a broad sector whose companies can be affected by factors including clinical-trial results, regulation, and changes in healthcare spending. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Humana (HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Shares of Humana stock traded up $3.28 on Monday, hitting $437.02. 1,194,135 shares of the company traded hands, compared to its average volume of 1,640,331. Humana has a 52 week low of $163.11 and a 52 week high of $456.50. The business has a 50-day simple moving average of $403.96 and a 200 day simple moving average of $312.27. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.74 and a current ratio of 1.65. The stock has a market capitalization of $52.48 billion, a P/E ratio of 42.52, a price-to-earnings-growth ratio of 2.67 and a beta of 0.65.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Shares of NYSE:HIMS traded down $2.60 during midday trading on Monday, reaching $23.40. 17,538,507 shares of the company were exchanged, compared to its average volume of 22,074,303. The stock has a market cap of $5.46 billion, a PE ratio of -37.33 and a beta of 2.53. The business’s fifty day moving average is $28.43 and its two-hundred day moving average is $26.94. Hims & Hers Health has a one year low of $13.74 and a one year high of $42.70. The company has a current ratio of 0.93, a quick ratio of 0.87 and a debt-to-equity ratio of 4.21.

Boston Scientific (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

Shares of BSX traded up $1.38 during midday trading on Monday, hitting $44.13. 6,961,163 shares of the company traded hands, compared to its average volume of 18,790,295. The firm has a 50 day moving average of $44.32 and a 200-day moving average of $55.70. Boston Scientific has a 52 week low of $39.57 and a 52 week high of $105.65. The stock has a market cap of $63.96 billion, a price-to-earnings ratio of 18.69, a PEG ratio of 1.27 and a beta of 0.60. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.81 and a current ratio of 1.36.

Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Shares of Stryker stock traded up $1.63 during trading hours on Monday, reaching $327.50. The company’s stock had a trading volume of 923,846 shares, compared to its average volume of 2,506,429. The stock has a market cap of $124.68 billion, a P/E ratio of 34.83, a P/E/G ratio of 2.24 and a beta of 0.78. Stryker has a one year low of $267.00 and a one year high of $389.33. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.18 and a quick ratio of 1.30. The firm has a 50 day moving average price of $292.37 and a 200-day moving average price of $323.59.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

GILD stock traded up $2.24 during midday trading on Monday, reaching $169.13. 1,330,497 shares of the company traded hands, compared to its average volume of 6,829,511. Gilead Sciences has a 52-week low of $116.88 and a 52-week high of $176.58. The company has a debt-to-equity ratio of 1.84, a quick ratio of 1.22 and a current ratio of 1.38. The business has a 50 day moving average of $153.04 and a 200-day moving average of $140.94. The firm has a market capitalization of $209.78 billion, a price-to-earnings ratio of -53.56 and a beta of 0.35.

Danaher (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Shares of Danaher stock traded up $3.33 during trading on Monday, hitting $233.58. The stock had a trading volume of 907,076 shares, compared to its average volume of 4,439,673. Danaher has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29. The firm’s fifty day simple moving average is $220.27 and its 200-day simple moving average is $201.60. The stock has a market cap of $164.33 billion, a PE ratio of 38.14, a PEG ratio of 2.89 and a beta of 0.76.

Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Medtronic stock traded up $1.59 during midday trading on Monday, reaching $103.39. The stock had a trading volume of 1,871,967 shares, compared to its average volume of 11,275,031. The company has a quick ratio of 1.54, a current ratio of 2.07 and a debt-to-equity ratio of 0.50. The firm has a market cap of $132.25 billion, a price-to-earnings ratio of 25.45, a price-to-earnings-growth ratio of 2.38 and a beta of 0.56. Medtronic has a 52-week low of $73.31 and a 52-week high of $106.33. The company has a fifty day moving average of $92.70 and a 200 day moving average of $88.45.